{'fraction_non_alphanumeric': 0.028428093645484948, 'fraction_numerical': 0.005016722408026756, 'mean_word_length': 5.112244897959184, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Clinical analysis of drug eruption due to iohexol (Omnipaque)].

We reported 7 cases of drug eruption due to Iohexol (Omnipaque) which was nonionic X-ray contrast agent without severe adverse reaction. They showed generalized edematous and erythematous plaques. The eruption appeared from 5 to 6 days after the examination when a patient had not been sensitized, or several hours after that when he/she had been already sensitized. No case showed any cross-sensitization with ionic contrast media, but some cases suggested the possibility of cross-sensitization among the nonionic contrast agents.